Click for best price
Nonsteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2023
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
This report aims to provide a comprehensive presentation of the global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). This report contains market size and forecasts of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in global, including the following market information:
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
We surveyed the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Type, 2022 (%)
- Paracetamol
- Ibuprofen
- Aspirin
- Naproxen
- Others
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Pfizer
- Boehringer Ingelheim
- Teva Pharmaceutical
- Hospira
- Lonza Group
- Mylan
- Aurobindo Pharma
- Dr. Reddy's Laboratories
- Actavis
- Wuxi Apptec
- Zhejiang NHU
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), market overview.
Chapter 2: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size in revenue.
Chapter 3: Detailed analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Overall Market Size
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2022 VS 2035
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
3.2 Top Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Ranked by Revenue
3.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies
3.4 Top 3 and Top 5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
3.6.1 List of Global Tier 1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Markets, 2022 & 2035
4.1.2 Paracetamol
4.1.3 Ibuprofen
4.1.4 Aspirin
4.1.5 Naproxen
4.1.6 Others
4.2 By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
4.2.1 By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
4.2.2 By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2035
4.2.3 By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2022 & 2035
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
5.2.1 By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
5.2.2 By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2035
5.2.3 By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2022 & 2035
6.2 By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
6.2.1 By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
6.2.2 By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2035
6.2.3 By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035
6.3.2 US Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.3.3 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.3.4 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035
6.4.2 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.3 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.4 U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.5 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.6 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.7 Nordic Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.4.8 Benelux Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035
6.5.2 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.5.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.5.4 South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.5.5 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.5.6 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035
6.6.2 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.6.3 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035
6.7.2 Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.7.3 Israel Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.7.4 Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
6.7.5 UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2035
7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.1.4 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.2.4 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.3.4 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Teva Pharmaceutical
7.4.1 Teva Pharmaceutical Company Summary
7.4.2 Teva Pharmaceutical Business Overview
7.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.4.4 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceutical Key News & Latest Developments
7.5 Hospira
7.5.1 Hospira Company Summary
7.5.2 Hospira Business Overview
7.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.5.4 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.5.5 Hospira Key News & Latest Developments
7.6 Lonza Group
7.6.1 Lonza Group Company Summary
7.6.2 Lonza Group Business Overview
7.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.6.4 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.6.5 Lonza Group Key News & Latest Developments
7.7 Mylan
7.7.1 Mylan Company Summary
7.7.2 Mylan Business Overview
7.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.7.4 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.7.5 Mylan Key News & Latest Developments
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Company Summary
7.8.2 Aurobindo Pharma Business Overview
7.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.8.4 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.8.5 Aurobindo Pharma Key News & Latest Developments
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Company Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.10 Actavis
7.10.1 Actavis Company Summary
7.10.2 Actavis Business Overview
7.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.10.4 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.10.5 Actavis Key News & Latest Developments
7.11 Wuxi Apptec
7.11.1 Wuxi Apptec Company Summary
7.11.2 Wuxi Apptec Business Overview
7.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.11.4 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.11.5 Wuxi Apptec Key News & Latest Developments
7.12 Zhejiang NHU
7.12.1 Zhejiang NHU Company Summary
7.12.2 Zhejiang NHU Business Overview
7.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.12.4 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.12.5 Zhejiang NHU Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Opportunities & Trends in Global Market
Table 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers in Global Market
Table 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints in Global Market
Table 4. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Global Market
Table 5. Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
Table 9. List of Global Tier 1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2035
Table 30. Novartis Company Summary
Table 31. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 32. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 36. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 40. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Teva Pharmaceutical Company Summary
Table 43. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 44. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Pharmaceutical Key News & Latest Developments
Table 46. Hospira Company Summary
Table 47. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 48. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 49. Hospira Key News & Latest Developments
Table 50. Lonza Group Company Summary
Table 51. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 52. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 53. Lonza Group Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 56. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Aurobindo Pharma Company Summary
Table 59. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 60. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 61. Aurobindo Pharma Key News & Latest Developments
Table 62. Dr. Reddy's Laboratories Company Summary
Table 63. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 64. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 65. Dr. Reddy's Laboratories Key News & Latest Developments
Table 66. Actavis Company Summary
Table 67. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 68. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 69. Actavis Key News & Latest Developments
Table 70. Wuxi Apptec Company Summary
Table 71. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 72. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 73. Wuxi Apptec Key News & Latest Developments
Table 74. Zhejiang NHU Company Summary
Table 75. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 76. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 77. Zhejiang NHU Key News & Latest Developments
List of Figures
Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type in 2022
Figure 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application in 2022
Figure 3. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
Figure 8. By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 9. By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 10. By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 12. By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 14. By Region - Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 15. By Country - North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 16. US Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 20. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 21. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 28. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 32. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 34. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2035
Figure 37. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2035
Figure 41. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
